Euan Macpherson
Impact in
- Reproductive Medicine top 0.5%
- Ovarian cancer diagnosis and treatment
- Oncology top 1%
- PARP inhibition in cancer therapy
Papers in
- Co-authors
- James Carmichael (3 shared papers)Gordon Rustin (3 shared papers)Michael Friedländer (3 shared papers)Jonathan A. Ledermann (3 shared papers)Philipp Harter (3 shared papers)Ronnie Shapira‐Frommer (3 shared papers)Daniela Matei (3 shared papers)Werner Meier (3 shared papers)
- Journals
- Journal of Clinical Oncology (5 papers)Annals of Oncology (1 paper)Pharmaceutical Statistics (1 paper)New England Journal of Medicine (1 paper)The Lancet Oncology (1 paper)
- Partner nations
- United KingdomUnited StatesBelgium
In The Last Decade
Euan Macpherson
13 papers receiving 3.0k citations
Euan Macpherson's Hit Papers
Peers
Comparison fields: 5 of 84
- Reproductive Medicine 797
- Oncology 2.2k
- Cancer Research 337
- Genetics 611
- Molecular Biology 1.2k
Countries citing papers authored by Euan Macpherson
This map shows the geographic impact of Euan Macpherson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Euan Macpherson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Euan Macpherson more than expected).
Fields of papers citing papers by Euan Macpherson
This network shows the impact of papers produced by Euan Macpherson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Euan Macpherson. The network helps show where Euan Macpherson may publish in the future.
Co-authors
The 25 scholars most cited alongside Euan Macpherson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Olaparib Maintenance Therapy in Platinum-Sensitive Relapsed Ovarian Cancer Hit paper breakdown → | 2012 | 1413 |
| 2 | Olaparib in patients with recurrent high-grade serous or poorly differentiated ovarian carcinoma or triple-negative breast cancer: a phase 2, multicentre, open-label, non-randomised study Hit paper breakdown → | 2011 | 889 |
| 3 | 2009 | 239 | |
| 4 | 2008 | 202 | |
| 5 | 2011 | 131 | |
| 6 | 2010 | 81 | |
| 7 | 2021 | 72 | |
| 8 | 2011 | 49 | |
| 9 | 2013 | 32 | |
| 10 | 2019 | 8 | |
| 11 | 2009 | 2 | |
| 12 | 2015 | 1 | |
| 13 | 2009 | 1 |
About Euan Macpherson
Euan Macpherson is a scholar working on Oncology, Genetics, Pulmonary and Respiratory Medicine, Reproductive Medicine and Surgery, having authored 13 papers that have together received 3.1k indexed citations. Recurring topics across this work include PARP inhibition in cancer therapy (6 papers), Estrogen and related hormone effects (3 papers), BRCA gene mutations in cancer (3 papers), Ovarian cancer diagnosis and treatment (3 papers), Lung Cancer Treatments and Mutations (2 papers), Pancreatic and Hepatic Oncology Research (1 paper), Statistical Methods in Clinical Trials (1 paper) and Advanced Breast Cancer Therapies (1 paper). The work is most often cited by research in Reproductive Medicine (797 citations), Oncology (2.2k citations), Cancer Research (337 citations), Genetics (611 citations) and Molecular Biology (1.2k citations). Euan Macpherson has collaborated with scholars based in United Kingdom, United States and Belgium. Frequent co-authors include James Carmichael, Gordon Rustin, Michael Friedländer, Jonathan A. Ledermann, Philipp Harter, Ronnie Shapira‐Frommer, Daniela Matei, Werner Meier, Ignace Vergote and Tamar Safra. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Pharmaceutical Statistics, New England Journal of Medicine and The Lancet Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.